5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.35%
Revenue growth similar to METSB.HE's 4.35%. Walter Schloss would see if both companies share industry tailwinds.
12.82%
Gross profit growth similar to METSB.HE's 12.82%. Walter Schloss would assume both firms track common industry trends.
27.13%
EBIT growth similar to METSB.HE's 27.13%. Walter Schloss might infer both firms share similar operational efficiencies.
27.13%
Operating income growth similar to METSB.HE's 27.13%. Walter Schloss would assume both share comparable operational structures.
27.59%
Net income growth comparable to METSB.HE's 27.59%. Walter Schloss might see both following similar market or cost trajectories.
121.43%
EPS growth similar to METSB.HE's 121.43%. Walter Schloss would assume both have parallel share structures and profit trends.
121.43%
Similar diluted EPS growth to METSB.HE's 121.43%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.96%
Share count expansion well above METSB.HE's 0.96%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.96%
Diluted share count expanding well above METSB.HE's 0.96%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-79.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-142.71%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-29.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
8.85%
5Y revenue/share CAGR similar to METSB.HE's 8.85%. Walter Schloss might see both companies benefiting from the same mid-term trends.
1.36%
3Y revenue/share CAGR similar to METSB.HE's 1.36%. Walter Schloss would assume both companies experience comparable short-term cycles.
-52.74%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
172.35%
5Y OCF/share CAGR is similar to METSB.HE's 172.35%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
-43.77%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
121.16%
Similar net income/share CAGR to METSB.HE's 121.16%. Walter Schloss would see parallel tailwinds or expansions for both firms.
152.75%
5Y net income/share CAGR similar to METSB.HE's 152.75%. Walter Schloss might see both on parallel mid-term trajectories.
17.95%
3Y net income/share CAGR similar to METSB.HE's 17.95%. Walter Schloss would attribute it to shared growth factors or demand patterns.
40.04%
10Y equity/share CAGR in line with METSB.HE's 40.04%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
41.47%
5Y equity/share CAGR is in line with METSB.HE's 41.47%. Walter Schloss would see parallel mid-term profitability and retention policies.
28.79%
3Y equity/share CAGR similar to METSB.HE's 28.79%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.14%
AR growth well above METSB.HE's 25.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.18%
Inventory growth well above METSB.HE's 10.18%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.64%
Similar asset growth to METSB.HE's 13.64%. Walter Schloss finds parallel expansions or investment rates.
12.97%
Similar to METSB.HE's 12.97%. Walter Schloss finds parallel capital usage or profit distribution strategies.
2.86%
Debt growth far above METSB.HE's 2.86%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-49.54%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.